Atossa Therapeutics, Inc. (ATOS)

5.80 +0.22 (+3.94%) USD  |  NASDAQ  |  May 06, 16:00
5.80 0.00 (0.00%) Pre-Market: 20:00
More

Atossa Therapeutics Free Cash Flow : -29.78M for Dec. 31, 2025

Free Cash Flow Chart

View Free Cash Flow for ATOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Celldex Therapeutics, Inc. -213.66M
Plus Therapeutics, Inc. -20.84M
Abeona Therapeutics, Inc. -84.30M
Cell Source, Inc. --
Kiora Pharmaceuticals, Inc. -10.07M

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) -10.54M
Cash from Investing (Quarterly) -0.007M
Free Cash Flow Per Share (Quarterly) -1.225
Free Cash Flow to Equity (Quarterly) -10.55M
Free Cash Flow to Firm (Quarterly) -10.55M
Free Cash Flow Yield -13.25%